Visby Medical Secures FDA Clearance for At-Home Flu & COVID-19 PCR Test

Shots: The US FDA has granted clearance to Flu and COVID-19 Test, an at-home PCR test capable of detecting multiple respiratory viruses, expanding its portfolio of over-the-counter molecular diagnostics The test delivers PCR-quality results in 30min. & detects COVID-19 and influenza A/B at home, enabling earlier diagnosis & timely treatment decisions, incl. access to antiviral therapies when they are most effective The newly cleared test builds on Visby’s existing at-home PCR platform and will be eligible for FSA & HSA reimbursement, while the company continues to expand nationwide access to its home diagnostics Ref: Businesswire  |  Image: Visby Medical | Press Release Related News: Median Technologies Receives CE Mark for eyonis LCS to Detect and Diagnose Lung Cancer PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Visby Medical Secures FDA Clearance for At-Home Flu & COVID-19 PCR Test appeared first on PharmaShots.